PRONESTYL Drug Patent Profile
✉ Email this page to a colleague
When do Pronestyl patents expire, and when can generic versions of Pronestyl launch?
Pronestyl is a drug marketed by Apothecon and is included in three NDAs.
The generic ingredient in PRONESTYL is procainamide hydrochloride. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pronestyl
A generic version of PRONESTYL was approved as procainamide hydrochloride by INTL MEDICATION on July 31st, 1984.
Summary for PRONESTYL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Clinical Trials: | 2 |
Patent Applications: | 4,108 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PRONESTYL at DailyMed |
Recent Clinical Trials for PRONESTYL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Jeffrey Moak | Phase 4 |
Mayo Clinic | Phase 3 |
Medtronic | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for PRONESTYL
US Patents and Regulatory Information for PRONESTYL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apothecon | PRONESTYL | procainamide hydrochloride | CAPSULE;ORAL | 007335-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apothecon | PRONESTYL | procainamide hydrochloride | TABLET;ORAL | 017371-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apothecon | PRONESTYL | procainamide hydrochloride | INJECTABLE;INJECTION | 007335-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apothecon | PRONESTYL | procainamide hydrochloride | TABLET;ORAL | 017371-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apothecon | PRONESTYL | procainamide hydrochloride | CAPSULE;ORAL | 007335-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |